James B Weissman Dicerna Pharmaceuticals Inc (DRNA) insider trading activity

James B Weissman is Chief Operating Officer & EVP of Dicerna Pharmaceuticals Inc. Currently has a direct ownership of 0 shares of DRNA, which is worth approximately $0. The most recent transaction as insider was on Dec 28, 2021, when has been sold 18,100 shares (Common Stock) at a price of $38.25 per share, resulting in proceeds of $692,325. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

James B Weissman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 28 2021	SELL Disposition due to a tender of shares in a change of control transaction	$692,325 $38.25 p/Share	18,100 Reduced 100.0%	0 Common Stock
Dec 15 2021	SELL Payment of exercise price or tax liability	$63,734 $38.05 p/Share	1,675 Reduced 8.47%	18,100 Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	-	3,775 Added 16.03%	19,775 Common Stock
Jul 06 2021	SELL Open market or private sale	$1,172,700 $39.09 p/Share	30,000 Reduced 65.22%	16,000 Common Stock
Jul 06 2021	BUY Exercise of conversion of derivative security	$272,700 $9.09 p/Share	30,000 Added 39.47%	46,000 Common Stock
Apr 16 2021	SELL Open market or private sale	$147,071 $29.99 p/Share	4,904 Reduced 23.46%	16,000 Common Stock
Feb 05 2021	SELL Open market or private sale	$193,140 $26.99 p/Share	7,156 Reduced 25.5%	20,904 Common Stock
Jan 12 2021	SELL Open market or private sale	$139,857 $24.08 p/Share	5,808 Reduced 17.15%	28,060 Common Stock
Jan 11 2021	SELL Open market or private sale	$91,162 $23.99 p/Share	3,800 Reduced 10.09%	33,868 Common Stock
Jan 08 2021	SELL Payment of exercise price or tax liability	$66,190 $23.29 p/Share	2,842 Reduced 7.02%	37,668 Common Stock
Jan 08 2021	BUY Exercise of conversion of derivative security	-	8,650 Added 17.6%	40,510 Common Stock
Dec 01 2020	SELL Open market or private sale	$109,916 $25.21 p/Share	4,360 Reduced 12.04%	31,860 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$14,911 $3.42 p/Share	4,360 Added 10.74%	36,220 Common Stock
Nov 02 2020	SELL Open market or private sale	$91,342 $20.95 p/Share	4,360 Reduced 12.04%	31,860 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$14,911 $3.42 p/Share	4,360 Added 10.74%	36,220 Common Stock
Oct 20 2020	BUY Exercise of conversion of derivative security	$29,700 $2.97 p/Share	10,000 Added 23.89%	31,860 Common Stock
Oct 15 2020	SELL Open market or private sale	$176,144 $20.2 p/Share	8,720 Reduced 28.52%	21,860 Common Stock
Oct 15 2020	BUY Exercise of conversion of derivative security	$29,822 $3.42 p/Share	8,720 Added 22.19%	30,580 Common Stock

Also insider at

DNAY

Codex DNA, Inc. Healthcare

JBW

James B Weissman

Chief Operating Officer & EVP

Lexington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Dicerna Pharmaceuticals Inc insider buys or sells DRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Dicerna Pharmaceuticals Inc

Track Activities on DRNA

Account